Emboline
PrivateLast Round
Debt
Mar 11, 2026
Total Funding Raised
$107M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Emboline operates in Healthcare & Life Sciences and is based in Santa Cruz, California. Its latest recorded funding round was a Debt round in March 2026.
Emboline is a medical device company that develops an embolic protection catheter to safeguard the arterial bed during percutaneous heart valve repair and replacement procedures by capturing and removing emboli to protect critical organs.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Emboline Comparables
Compare Emboline with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Transverse Medical | 92% | |
| Filterlex Medical | 92% | |
| Protembis GmbH | 91% |
For institutional investors. Book with your work email.
Emboline Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Mar 11, 2026 | ||||
| Series D | May 25, 2021 | ||||
| Series C | Jan 5, 2021 | ||||
| Corporate Funding | Jan 31, 2020 | ||||
| Series B | Apr 19, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Emboline Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Trinity Capital | Debt |
| SV Tech Ventures | Series D, Series B |
| Matrix Capital Management | Series D |
| SV Tech | Series D |
| ShangBay Capital | Series D, Series B |
| Global Assets Investment, LLC | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 601% MoM, from 374 to 2.6K.
- May 17, 2026
Monthly visitors grew 65% MoM, from 1K to 1.7K.
For institutional investors. Book with your work email.
Emboline Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Emboline's valuation, stock price, and market status.
Is Emboline a public or private company?
Emboline is a private company.
What is the current stock price of Emboline?
Emboline is a private company, so its shares have no public market price. Caplight tracks Emboline's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Emboline worth (valuation)?
Valuation information for Emboline is not publicly available.
Can I buy Emboline stock?
Emboline shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Emboline's last funding round?
Emboline's most recent funding round was Debt on March 11, 2026.
Who are the main investors in Emboline?
Key investors in Emboline include Trinity Capital, SV Tech Ventures, Matrix Capital Management.
Will Emboline IPO soon?
No public IPO plans have been announced for Emboline.
How can I track Emboline secondary market activity?
Caplight tracks bids, offers, and trades in Emboline's shares on secondary markets.